Shareholding disclosure

Santhera Pharmaceuticals Holding Ltd

Declared position

10.23%

Threshold

Crossed upwards

Timeline

Published

29.04.2008

Transaction

21.04.2008

Transfer date

21.04.2008

Voting rights breakdown

Voting rights acquired10.23%
Voting rights sold0%
Below threshold0%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T6071D5828

Beneficial owner

Santhera Pharmaceuticals Holding Ltd

Declared address

Santhera Pharmaceuticals Holding Ltd., Liestal

Year of allocation / Number of Options / Exercise Price CHF 2002/ 4,460 /1.00 20027 /709/60.25 2003/ 32,860/ 59.44 2003/ 982 /60.25 2004/ 8,617 /1.00 2004 /38,472 /59.44 2004 /8,999 /60.25 2005 /11,339/ 59.44 2006 /96,344 /1.00 2006 /40,200/ 59.44 2006 /6,300 /82.58 2007 /18,000 /1.00 2007 /11,339 /59.44 2007 /1,600 /89.80 2007/ 2,900/ 101.80 2007/ 10,000 /106.80 2007/ 320 /114.50 2008 /4,000 /95.70 2008/ 9,000/ 72.70 2008 /12,600 /77.50

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open